Who founded Admabiologics?

Admabiologics was founded by Adam S. Grossman, Jerrold B. Grossman.

Who are Admabiologics's investors?

Admabiologics's investors include Aisling Capital.

How much funding has Admabiologics raised?

Admabiologics has disclosed $17M raised across 1 of its 2 known rounds.

Where is Admabiologics headquartered?

Admabiologics is headquartered in Hackensack, US.

Admabiologics

NASDAQ: ADMA

Hackensack, US · 1 known investors

Find your way into Admabiologics

690 people in our graph share verified history with the Admabiologics team — schools, employers, funds. One of them is your warm intro.

Hal Pazunlockedknows Terry Kohler · together at Johnson & Johnson (overlapped)

×7knows the team · via American University

×4knows the team · via UNC Kenan-Flagler Business School

ADMA Biologics is a vertically integrated manufacturer that develops and commercializes plasma-derived biologic therapies for immune-compromised patients, and operates plasma collection centers. The company markets immunoglobulin products and is a publicly traded US biopharmaceutical company.

Advanced Manufacturing Biotech Healthtech Medical Devices

Founders & leadership

Adam S. Grossman inFounder, President & CEOAdam S. Grossman is founder, president and CEO of ADMA Biologics, a publicly traded biopharmaceutical manufacturer of plasma-derived immunoglobulin therapies and operator of plasma collection facilities. He has extensive background in the biotech, medical device, and plasma protein industries.

Jerrold B. GrossmanCo-founder & Vice Chairman

Kaitlin Kestenberg inChief Operating Officer & Senior Vice President of ComplianceKaitlin Kestenberg is Chief Operating Officer and Senior Vice President of Compliance at ADMA Biologics, where she oversees regulatory compliance, quality assurance, and project management for clinical programs and manufacturing operations. Her background includes leading regulatory affairs strategy, managing FDA submissions including the ASCENIV™ BLA, and preparing the company for FDA inspections.

Terry Kohler inChief Financial Officer & TreasurerTerry Kohler is Chief Financial Officer and Treasurer at ADMA Biologics, a publicly traded biopharmaceutical manufacturer of plasma-derived therapies. He brings over 20 years of finance leadership experience in biopharma, specialty pharmaceuticals, and investment banking, with expertise in capital strategy, M&A, and scaling organizations from development through commercial stages.

Paul Terence Kohler, Jr.Chief Financial Officer and Treasurer

Brad L. Tade inChief Financial Officer and TreasurerBrad L. Tade is Chief Financial Officer and Treasurer at ADMA Biologics, where he oversees global operations finance. He brings over 20 years of experience in finance roles within medical device and pharmaceutical companies, with focus on manufacturing operations, supply chain strategy, and financial planning.

Board

Dov GoldsteinBoard directorManaging Partner at Aisling Capital

Bryant E FongBoard director

Steven A Elms inBoard directorManaging Partner at Aisling Capital

Eric I RichmanBoard director

Investors · 1

Aisling CapitalNew York

Reported raises · per SEC filings

Form D private placements

$17M disclosed across 1 of 2 rounds · 2007–2012

▶Undisclosed amountofferedFeb 2012 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Dov GoldsteinDirector
Adam S GrossmanExecutive Officer, Director
Eric I RichmanDirector
Bryant E FongDirector
Steven A ElmsDirector
Jerrold B GrossmanDirector

First sale: Feb 2012
Incorporated: Corporation, Delaware
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

StockTwits37 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

Companies competing with Admabiologics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Admabiologics do?: ADMA Biologics is a vertically integrated manufacturer that develops and commercializes plasma-derived biologic therapies for immune-compromised patients, and operates plasma collection centers. The company markets immunoglobulin products and is a publicly traded US biopharmaceutical company.
Who founded Admabiologics?: Admabiologics was founded by Adam S. Grossman, Jerrold B. Grossman.
Who are Admabiologics's investors?: Admabiologics's investors include Aisling Capital.
How much funding has Admabiologics raised?: Admabiologics has disclosed $17M raised across 1 of its 2 known rounds.
Where is Admabiologics headquartered?: Admabiologics is headquartered in Hackensack, US.